ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 3.010
-0.125 (-3.99%)
May 7, 2025, 1:22 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 15.67 million as of May 7, 2025. Its market cap has increased by 72.57% in one year.
Market Cap
15.67M
Enterprise Value
14.58M
Revenue
-69.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.01
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 15.67M, a decrease of -56.62%. That is a compound annual growth rate of -4.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.92B |
| GSK plc | 58.67B |
| Haleon | 36.11B |
| Smith & Nephew | 9.34B |
| ConvaTec Group | 5.36B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.37B |